Premium Information is available for this item - Upgrade for $1 a day
4820-01-656-4725
Valve Flow Divider
4820016564725 016564725 4503637A
January 2023
3
Marketplace 4820-01-656-4725
Request a Quotation from participating marketplace vendors
Related Documents 4820-01-656-4725 1+ Documents (More...)
4820-01-656-4725 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-48/fsc-4820/us 4820-01-656-4725
RQST NE Updated Every Day 4820-01-656-4725 RQST Updated Every Day 4820-01-656-4725 RQST NE Related Documents
Restrictions 4820-01-656-4725
4820-01-656-4725 is a Valve Flow Divider that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item has been confirmed as a Critical Munitions List Item or a Sensitive Commerce Control List Item and cannot be in the possession of any party anywhere in the World who is not an authorized NATO Government. Any other possessor of this item should mutilate it now as possession violates international and local laws. This item is a confirmed Commerce Control List Item (CCLI). This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 4820-01-656-4725
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 4820-01-656-4725
- Republic of Korea (ZH01)
- Effective Date:
- 1 Jul 2016
Approved Sources 4820-01-656-4725
- Part Number
- Manufacturer
- Status
- 4503637A
- Manufacturer
- 55820 - Rtx Corporation (Active)
- Primary Buy
- Primary Buy
Datasheet 4820-01-656-4725
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- End Item Identification [AGAV]
- Combustor Assembly, Auxiliary Power System;
- Part Name Assigned By Controlling Agency [CXCY]
- Flow Divider Assembly;
NATO Stock Numbers Related to 4820-01-656-4725
Freight Information 4820-01-656-4725
4820-01-656-4725 has freight characteristics managed by the Republic of Korea.. 4820-01-656-4725 has a variance between NMFC and UFC when transported by rail and the description should be consulted.